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1. Introduction
Ultrasonography (US) is one of the most widely used imaging procedures. The main advan‐
tages of this investigation over others include it being non-invasive and safe, with no radiation
exposure. In addition, its images are provided in “real time”, delivering dynamic images with
both anatomical and functional information. The images acquired by ultrasonography are
sectional and easy to understand. The method is accurate, without distortion. The major
disadvantage of ultrasonography is that it is operator dependent, requiring a large number of
examinations performed personally in order to reach a high level of proficiency [1]. Additional
issues include poorer performance if gas, adipose tissue or bony structures come between the
transducer and the region of interest. A number of artifacts, such as reverberations and false
reflections, may interfere with the acquisition of the ultrasound image, and need to be
recognized and avoided.
Ultrasonography is practiced on a daily basis, both by physicians and specialized personal.
Now it is widely accepted that a good correlation of the ultrasonographic data with clinical
information is necessary in order to achieve an optimal performance [2]. The proposal that
access to US should become generalized and be practiced by every physician within their
specialty as a way of completing the clinical examination is increasingly voiced [3]. Liver
ultrasonography has been recognized for a long time as an application of US efficient in
detecting diffuse liver conditions, hepatic tumors, vascular abnormalities, post-traumatic
lesions as well as in guiding interventional procedures [4, 5, 6, 7, 8, 9].
Ultrasonography is a multimodal examination, meaning that the final report and basis for the
diagnosis, is a complex one, obtained through multiple procedures. Each procedure brings
specific data in relation to the underlying principle of operation. The main US component is
bidimensional  ultrasonography (“grey scale” ultrasound).  It  consists  of  sectional  images,
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presented on a grey scale, with each shade of grey representing a density (in fact, an acoustic
impedance). “Grey scale” ultrasonography is a dynamic examination that allows the overall
evaluation of the liver, with measurements of the hepatic lobes, identification of liver seg‐
ments, as well as characterization of texture and echogenicity (in relation with the degree of fat
infiltration and fibrosis). Grey scale US also enables the detection and evaluation of normal
anatomical structures (bile ducts, vessels) and of pathological elements (mainly liver masses).
Elastography, an additional component, realizes a quantitative and qualitative (using color
coding) characterization of the elasticity of the liver parenchyma [10, 11, 12]. The Doppler
procedure represents the basis for evaluating the flow within liver vessels. There is also the
spectral version of this application which provides quantitative data (direction of flow, flow
velocities, debits, etc) and a color coded version that gives information regarding the presence
and the direction of blood flow in the region of interest [13, 14].  Ultrasonography using
intravenous (i.v.) contrast agents (CEUS) is a procedure that observes the blood flow in a reference
region by revealing the harmonic echoes [15]. Recently, a number of other applications have
been developed, many of them based on the mathematical processing of the image. These are
meant to optimize the information, enabling quantification, for example, and even allow an
automatization of the US diagnosis [16]. Generally speaking, ultrasonography is often the first
imaging exploration performed after the clinical exam. As a method, it has proven its value in
many respects, including in the detection of liver tumors. In its standard form, however, it is not
sensitive enough to characterize and establish the nature of these lesions, despite the many
technical advances that have been made [17].
2. The principles and physics of contrast enhanced ultrasonography
The use of contrast in ultrasonography represents a huge advance for this investigation. Even
though Doppler ultrasound has a certified role and is the recognized technique for detecting
vascular abnormalities in large vessels, it is only after the introduction of contrast agents that
we can talk about an exact and reproducible evaluation of microcirculation with the help of
ultrasound.
Contrast enhanced ultrasonography (CEUS) consists of injecting gas ‘microbubbles’ into the
systemic circulation. The contrast agent (CA) used is made of small bubbles close in size to red
blood cell. These microbubbles contain low soluble gases encapsulated into a biocompatible
membrane which may have variable composition – lipids, proteins or biopolymers. The
membrane can be either rigid or flexible with a thickness between10-200 nm [18]. Basically,
like in any other contrast based imaging procedure, the CEUS exam consists of a “bolus”
administration of the contrast media through a superficial peripheral vein. Due to their
extremely small size, the microbubbles pass through the pulmonary circulation and then
disseminate into the systemic circulation through the arterial blood stream. The contrast agent
remains in the blood stream for about 4-5 minutes. There is also a parenchymal phase at the
level of the liver and spleen because the contrast agent is captured by the reticuloendothelial
system and/or it becomes adherent to the hepatic sinusoids [19]. Unlike the contrast agents
used for CT or MRI, the gas used for CEUS is eliminated through the air-ways 10-15 minutes
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after administration, while the substances that make up the membrane are eliminated through
the kidney or metabolized by the liver. The contrast media used in ultrasonography have no
toxicity and the technique is less harmful to patients when compared with other investigations.
The contrast enhanced examination is based on the emission of harmonic echoes by the CA
when this passes through an ultrasound beam that has a mechanical index of 0.09 – 0.11. The
mechanical index (MI) represents a value that is directly correlated with the biological effect
of the ultrasounds upon the tissues. This index is variable depending on the ultrasound
machine, but it is basically conditioned by the acoustic power of the ultrasounds beam. The
acoustic power (AP), measured in Pascals, represents the energy of the sound beam acting on
a target, for example a group of red cells or the contrast agent inside the blood stream. Usually,
at high values of the AP, up to MegaPa, the micro bubbles are “broken” and an irregular, non-
linear signal is generated. At low values of the AP (30-70 kPa) the microbubbles vibrate in a
particular, non-linear manner, producing alternating contractions and relaxations, thus
generating harmonic echoes.
The ultrasound equipment produces a separation of the harmonic echoes generated by the CA
within the blood stream from the echoes generated by the surrounding tissues. This separation
may be realized by modulating the phase and the amplitude of the US beam. There are multiple
US generating techniques within the transducer that generate harmonic echoes within the CA.
Techniques of pulse inversion (“Pulse Inversion”, “Power Pulse Inversion”, “Cadence
Contrast Pulse Sequencing”) perform a “subtraction” of the tissue echoes by alternative
emission of pulses found in an inversed phase. A “Vascular Recognition Imaging” technique
introduces the Doppler principle in the analysis of the returned signals, allowing a color coding
of the red cells in relation to their direction of flow.
Practically, CEUS consists of an injection of a contrast agent, prepared at the time of use, into a
cubital vein. This is followed by a bolus of 10 cc saline solution. The region of interest, previous‐
ly identified during the “grey scale” exam, is continuously observed on the monitor. The monitor
may be divided into two identical, real-time images, one using fundamental, “grey scale”, echoes
and the other one using harmonic echoes obtained by exposure to a sound beam with a low
mechanical index (0.09 – 0.11). The examination continues for 90 seconds. After this time the
exploration may be intermittent. CEUS is focused on a single region of interest, usually a mass.
The exploration of another mass requires either a “breaking” of the bubbles inside the mass,
performed with special software or using the CFM technique, or a repetition of the CEUS exam
after another contrast administration focused on the second lesion. There are no risks for the
patient, so the injection of the CA can be repeated as often as needed.
Using CEUS in the exploration of the liver has special features that arise from the double
vascularity of this organ – through the portal vein (two thirds) and through the arterial system
(one third). The sequence of blood entering the liver is first arterial (up to 30 seconds) and then
portal (30 to 90 seconds, with little variation). This vascular discrimination (similar to the one
obtained by contrast CT or MRI) allows for gathering information regarding the circulatory
bed (types of feeding vessels, tumor circulatory volume) of a tumor. The presence of arterio‐
venous communications is characteristic for the neoplastic circulation and in CEUS is ex‐
pressed by the “wash-out” process. This phenomenon begins at the end of the arterial phase
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and/or during the venous phase, is persistent and is characteristic for neoplastic processes in
90 % of cases [20]. There are studies that correlate the wash-out speed of the tumor with its
aggressiveness, attributing CEUS a prognostic value.
An important component of the CEUS exam is represented by the quantitative analysis of the
data. This consists of a representation in time of the acoustic impedance variation in one or
more predetermined regions of interest. A graphic is obtained that can be correlated with
hemodynamic parameters, like the time of maximum systolic ascent in the region of interest,
the volume of the circulatory bed, presence and scale of the arteriovenous shunts, etc. All these
elements are indicators for the quality of a specific circulatory bed [21].
The advantages of the CEUS technique are summarized in Table 1 and include the lack of
ionizing radiation exposure, the non invasive character of the method, as well as very good
spatial and temporal resolution [22]. The method is safe for patients, with very few cases of
anaphylaxis having been reported (about 0.001% of the total number of investigations). It is
therefore recommended in some centres as the firstline procedure for assessment of liver
nodules. Contrast CT not only exposes the patient to ionizing radiation, but iodine based
contrast agents can be toxic and produce allergic reactions. CT scan imaging may also be less
sensitive, “losing” or failing to capture the early arterial phase in highly vascular tumors.
• very good spatial resolution;
• high temporal resolution – it is a “real time” examination;
• it reveals very slow blood flow or stagnant blood streams;
• non-ionizing examination;
• lack of anaphylaxis;
• the contrast agent is eliminated through the air-ways;
• can be repeated as often as needed
Table 1. Advantages of the CEUS examination
It should also be recognized that CEUS exploration has a number of limitations, as summarized
in Table 2. It is dependent on expensive and sophisticated equipment that raises the cost of the
investigation. The harmonic image is depending on good quality 2D image. Deeper lesions are
harder to visualize and attenuation may represent a limit in detecting tumors located further
from the transducer. Last, but not least the investigation is operator dependent and often the
information that is obtained must be correlated with the clinical data and biochemical
functional information.
• expensive and sophisticated equipment;
• high cost of the exploration compared with the standard investigation;
• operator dependent;
• it depends on a good quality 2D image;
• low quality information in case of attenuation like in liver steatosis;
• it investigates a single region of interest;
Table 2. Limitations of CEUS examination
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3. CEUS and the assessment of benign liver tumors
The imaging/ultrasonographic contribution to the detection of benign liver tumors is not
insignificant. Benign lesions are numerous, affecting about 20% of the population [23]. They
are frequently detected following ultrasonography, which is widely available and represents
a common investigation in any abdominal complaint. CEUS exploration can distinguish
between benign and malignant tumors and consequently can halt the diagnostic algorithm
when a mass detected by 2D ultrasonography is characterized by CEUS as being benign. In
this way the numbers of investigations is optimal and the patient's discomfort is significantly
reduced. There a multiple benign liver masses, however, and not all of them have CEUS
characteristic features. Their ultrasonographic aspect is often similar and their discrimination
may require additional criteria [24]. Among the lesions that present specific circulation
patterns which can be defined when analyzed by CEUS are cysts, hemangiomas, adenoma and
benign focal hyperplasia (table 3).
Tumor Arterial phase Portal phase Delayed phase 2D feature
Cyst No uptake No uptake No uptake Transsonic
Hemangioma “Ring-like” peripheral
uptake
Centripetal
enhancement
resembling “buds”
Complete uptake Hyperechoic
Well-defined
Compressibility
“Mirror” effect
Focal nodular
hyperplasia
Central enhancement
with a “spoked wheel”
distribution of the CA
Complete
enhancement with
an isoechoic
appearance
compared with liver
parenchyma
Isoechoic aspect
when compared with
the liver parenchyma
Echoic scar in the
centre of the lesion
Arterial signal in the
centre of the tumor
Adenoma Inhomogeneous
uptake
Discrete wash-out
Iso or hypoechoic
aspect compared to
liver parenchyma
Discrete wash-out,
Iso or hypoechoic
aspect compared to
liver parenchyma
Hypoechoic nodule
Non-cirrhotic liver
(*) The information presented in the table is referring to typical situations. In practice, there are variations of the 2D or
CEUS aspects that require further investigations
Table 3. CEUS and 2D ultrasonographic features in cases of benign liver lesions. (*)
Liver hemangioma. It is the most frequently encountered benign tumor of the liver. It is most
often found in women and has a prevalence of about 0.4 – 7.4 % in the population [25]. The
mass consists of a vascular, capillary or venous, bundle, rich in fibrotic bands and with no
capsule. It may be frequently associated with other benign tumors like cysts or adenomas.
Hemangiomas are usually asymptomatic (in very rare cases, when extremely large they may
cause a distension of the liver capsule and thrombocytopenia) and have a slow, self-limiting
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development. In most cases there is just one lesion, but there is also a multicentric type. The
grey scale US appearance of hemangiomas is fairly characteristic: a well circumscribed,
hyperechoic liver mass, with a slightly hypoechoic centre or periphery (figure 1).
Figure 1. Liver hemangioma. The lesion is found within the left lobe (asterisk) and has a characteristic appearance on
“grey scale” ultrasound: well circumscribed, hypoechoic nodule with irregular margins.
Hemangiomas do not cause vascular or biliary ducts invasion. But they may produce an effect
of posterior acoustic enhancement. On closer inspection the operator can observe this effect
by changing the aspect of the transducer in combination with profound compression. When
the hemangioma is located in contact with the diaphragm it can generate a “mirror” effect that
leads to a reproduction of the image in the lung parenchyma. Hemangiomas do not usually
show signal on the Doppler investigation as flow velocities inside them are very low. Addi‐
tionally, in many cases intratumoral ischemia or fibrotic scars will develop. Often, the
ultrasonographic diagnostic criteria are clear enough and in most situations the conventional
ultrasound which first detects the nodule, is sufficient to characterize the lesion. But there are
circumstances when 2D ultrasound is not sufficient for tumor characterization and thus CEUS
is needed. In the presence of severe steatosis as well as in patients undergoing chemotherapy
for various neoplastic conditions, the appearance of a hemangioma may alter and become
“atypical”. Also in patients with liver cirrhosis, a hemangioma may be misinterpreted for a
hepatocellular carcinoma or a large regeneration nodule. Extremely large hemangiomas may
have a heterogeneous structure due to possible hemorrhage or ischemia developed inside the
lesion, which can alter their appearance. Last but not least, CEUS can be very useful in
reassuring both operator and patient that a nodule accidentally found during an ultrasound
exam is benign.
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The appearance of a hemangioma on CEUS is characterized by a peripheral, ring-like, clear
enhancement during the arterial phase (figure 2a). This process is continuous and slow and is
followed the appearance of contrast “buds” inwardly oriented (figure 2b). In the end, after
several minutes of observation, a complete enhancement of the hemangioma is observed
(figure 2c). Therefore a pattern of progressive and centripetal enhancement of a nodule is the
characteristic feature for the diagnosis of hemangioma [26].
Figure 1. Liver hemangioma. The lesion is found within the (asterisk) has characteristic appearance “grey scale” ultrasound:
circumscribed, hypoechoic nodule with irregular margins.
Hemangiomas cause vascular biliary ducts invasion. But they may produce effect posterior acoustic enhancement.
closer inspection the can observe that this effect by changing the aspect the transducer combination with
profound compression. When the hemangioma is located contact with the diaphragm can generate effect that leads
reproduction the image the lung parenchyma. Hemangiomas usually show signal the investigation as
velocities inside them very Additionally, many cases intratumoral ischemia fibrotic scars develop. Often,
the ultrasonographic diagnostic criteria clear enough most situations the conventional ultrasound which first detects the
nodule, is sufficient characterize the lesion. But there circumstances when ultrasound is sufficient tumor
characterization thus is the presence severe steatosis as as patients undergoing chemotherapy
various neoplastic conditions, the appearance hemangioma may become “atypical”. Also patients with liver
cirrhosis, hemangioma may misinterpreted hepatocellular carcinoma large regeneration nodule. Extremely large
hemangiomas may have heterogeneous structure due possible hemorrhage ischemia developed inside the lesion, which can
their appearance. Last but least, can very useful reassuring both that nodule
accidentally found during ultrasound is benign.
The appearance hemangioma is characterized by peripheral, ring like, clear enhancement during the phase
(figure This process is continuous slow is the appearance contrast “buds” inwardly (figure
the end, several minutes observation, co plete enhancement the hemangioma is observed (figure 2c) Therefore
progressive centripetal enhancement nodule is the characteristic feature the diagnosis hemangioma
 
Figure 2. Liver hemangioma. during the phase seconds since contrast injection) shows “ring”
around the nodule. The appearance the contrast “buds” suggests the centripetal character progression. c. the the phase
there is complete enhancement the lesion with contrast agent.
The uptake may take variable amounts time, tens seconds several minutes (even tens minutes), depending the
size the lesion the type circulatory (figure 3a; figure 3b; figure 3c)
(a) (b) 
(c) 
Figure 2. Liver hemangioma. a. CEUS performed during the arterial phase (18 seconds sin e contrast media injection)
shows a well defined “ring” around the nodule. b. The appearance of the contrast “buds” suggests the centripetal
character of CA progression. c. At the end of the arterial phase there is complete enhancement of the lesion with con‐
trast agent.
The uptake may take variable amounts of time, from tens of seconds to several minutes (even
tens of minutes), depending on the size of the lesion and the type of circulatory bed (figure
3a; figure 3b; figure 3c).
A particular type of hemangioma is the arterialized type. It is characterized by accelerated,
complete uptake during the arterial phase. It corresponds to circulatory alterations character‐
ized by an important arterial flow. In this situations a differential diagnosis with hypervascular
metastases or HCC is difficult and thus a correlation with other imaging techniques is
mandatory [27].
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Figure 3. a. “Atypical” liver hemangioma. This is the case of a female patient undergoing chemotherapy for breast
cancer. There is increased echogenicity of the liver suggesting therapy induced dystrophy. In the middle of the right
lobe there is a hypoechoic, solid lesion that raises the possibility of a liver metastasis. b. CEUS exam shows a “ring”
enhancement of the lesion during the arterial phase (16th second). c. CEUS exam reveals a complete enhancement of
the nodule at the end of the portal phase (70th second). The enhancement process was centripetal (from periphery
towards the centre). The diagnosis is certainly of hemangioma. The case demonstrates the role of the CEUS in patients
undergoing oncologic treatments who present liver nodules.
Liver cysts. Liver cysts are serous collection circumscribed by cuboidal epithelium. They are
frequently encountered during 2D ultrasound, especially in women. Usually they measure
less than 20 mm and can present as single or multiple lesions. An involvement of the entire
liver is rare. The grey scale US aspect of cysts is that of a well defined, transsonic lesion with
posterior acoustic enhancement. The walls of a cyst are very thin and often difficult to
distinguish. Inside the cyst there may be thin septa and sometimes deposits. Cysts show no
signal on the CFM (color flow mode) interrogation. A hydatid cyst additionally presents
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